Taurine reduces atherosclerotic lesion development in apolipoprotein E-deficient mice

Advances in Experimental Medicine and Biology

Volumn 483, Issue , 2000, Pages 193-202

  Kondo, Y ^a   Murakami, S ^a   Oda, H ^b   Nagate, T ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E; CHOLESTEROL; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; AORTA; ARTERIOSCLEROSIS; ARTICLE; BLOOD; BODY WEIGHT; C57BL MOUSE; DIET SUPPLEMENTATION; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BODY WEIGHT; CHOLESTEROL; DIETARY SUPPLEMENTS; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0034585558     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (28)

1. Huxtable, R.J., 1992, Physiological actions of taurine. Physiol. Rev. 72:101-163.
2. Sugiyama, K., Kushima, Y., and Muramatsu, K., 1984, Effect of methionine, cysteine, and taurine on plasma cholesterol level in rats fed a high cholesterol diet. Agric. Biol. Chem. 48:2897-2899.
3. Murakami, S., Yamagishi, I., Asami, Y., Ohta, Y., Toda, Y., Nara, Y., and Yamori, Y., 1996, Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 52:303-313.
4. Nakamura-Yamanaka, Y., Tsuji, K., and Ichikawa, T., 1987, Effect of dietary taurine on cholesterol 7α-hydroxylase activity in the liver of mice fed a lithogenic diet. J. Nutr. Sci. Vitaminol. 33:239-243.
5. Petty, M.A., Kintz, J., and Di Francesco, G.F., 1990, The effects of taurine on atherosclerosis development in cholesterol-fed rabbits. Eur. J. Pharmacol. 180:119-127.
6. Kibe, A., Wake, C., Kuramoto, T., and Hoshita, T., 1980, Effect of dietary taurine on bile acid metabolism in guinea pigs. Lipids 15:224-229.
7. Truswell, A.S., McVeigh, S., Mitchell, W.D., and Bronte-Stewart, B., 1965, Effect in man of feeding taurine on bile acid conjugation and serum cholesterol levels. J. Atheroscler. Res. 5:526-529.
8. Plump, A.S., Smith, J.D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J.G., Rubin, E.M., and Breslow, J.L., 1992, Severe hypercholesterolemia and atherosclerosis in apoE-deficient mice created by homologous recombination in ES cells. Cell 71:343-353.
9. Zhang, S.H., Reddick, R.L., Piedrahita, J.A., and Maeda, N., 1992, Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471.
10. Palinski, W., Ord, V.A., Plump, A.S., Breslow, J.L., Steinberg, D., and Witztum, J.L., 1994, ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14:605-616.
11. Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A., and Ariram, M., 1997, Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17:2744-2752.
12. Pratico, D., Tangirala, R.K., Rader, D.J., Rokach, J., and Fitzgerald, G.A., 1998, Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nat. Med. 4:1189-1192.
13. Cynshi, O., Kawabe, Y., Suzuki, T., Takashima, Y., Kaise, H., Nakamura, M., Ohba, Y., Kato, Y., Tamura, K., Hayasaka, A., Higashida, A., Sakaguchi, H., Takeya, M., Takahashi, K., Inoue, K., Noguchi, N., Niki, E., and Kodama, T., 1998, Antiatherogenic effects of the antioxidant BO-653 in three different animal models. Proc. Natl. Acad. Sci. U.S.A. 95:10123-10128.
14. Hayek, T., Attias, J., Smith, J., Breslow, J.L., and Keidar, S., 1998, Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice. J. Cardiovasc. Pharmacol. 31:540-544.
15. Bourassa, P.K., Milos, P.M., Gaynor, B.J., Breslow, J.L., and Aiello, R.J., 1996, Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 93:10022-10027.
16. Sugiyama, F., Haraoka, S., Watanabe, T., Shiota, N., Taniguchi, K., Ueno, Y., Tanimoto, K., Murakami, K., Fukamizu, A., and Yagami, K., 1997, Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated reninangiotensin system. Lab. Invest. 76:835-842.
17. Murakami, S., Kondo-Ohta, Y., and Tomisawa, K., 1999, Improvement in cholesterol metabolism in mice chronic treatment of taurine and fed a high-fat diet. Life Sci. 64:83-91.
18. Yagi, K., 1976, A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:212-216.
19. Ross, R., 1995, Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:791-804.
20. Pasantes-Morales, H. and Cruz, C., 1985, Taurine and hypotaurine inhibit light-induced lipid peroxidation and protect rod outer segment structure. Brain Res. 330:154-157.
21. Alvarez, J.G. and Storey, B.T., 1983, Taurine, hypotaurine, epinephrine and_albumin inhibit lipid peroxidation in rabbit spermatozoa and protect against loss of motility. Biol. Reprod. 29:548-555.
22. Yamamoto, A., Matsuzawa, Y., Yokokawa, S., Funahashi, T., Yamamura, T., and Kishino, B., 1986, Effect of probucol on xanthomata regression in familial hypercholesterolemia. Am. J. Cardiol. 27:29H-35H.
23. Davigon, J., Nestruck, A.C., Alaupovic, P., and Bouthillier, D., 1986, Severe hypoalphalipoproteinemia induced by a combination of probucol and clofibrate. Adv. Exp. Med. Biol. 201:111-125.
24. Carew, T.E., Schwenke, D.C., and Steinberg, D., 1987, Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage -rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. U.S.A. 84:7725-7729.
25. Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Narumiya, S., and Kawai, C., 1988, Prevention of atherosclerotic progression in Watanabe rabbits by probucol. Am. J. Cardiol. 25:13-19.
26. Sunny, H.Z., Reddick, R.L., Avdierich, E., Surles, L.K., Jones, R.G., Reynolds,_J.B., Quarfordt, S.H., and Maeda, N., 1997, Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J. Clin. Invest. 99:2858-2866.
27. Moghadasian, M.H., McManus, B.M., Godin, D.V., Rodrigues, B., and Frohlich, J.J., 1999, Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice. Circulation 99:1733-1739.
28. Sugiyama, K., Ohishi, A., Ohnuma, Y., and Muramatsu, K., 1989, Comparison between the plasma cholesterol-lowering effects of glycine and taurine in rats fed on high cholesterol diets. Agric. Biol. Chem. 53:1647-1652.